In partnership with

Thanks for being a valued subscriber! We've got some exciting deals and important travel updates to share with you today.

🌟 Singapore Airlines Award Sale Alert!

Singapore KrisFlyer just launched a 20% off sale on economy and premium economy awards. This is separate from their monthly Spontaneous Escapes and covers more routes. Perfect timing to use those Chase or Amex points!

🎯 Hot Point Buying Opportunities

  • JetBlue: Up to 130% bonus (1.4¢ per point)

  • Wyndham: 80-90% bonus (0.68-0.72¢ per point) - Best offer ever!

  • Choice: 45% discount (0.57¢ per point)

✈️ Airline Updates

  • Alaska & Hawaiian: New joint program offering free cocktails for Atmos Rewards Summit cardholders

  • Air France: Rolling out free Starlink Wi-Fi (complete by late 2026)

  • JFK Airport: Rideshare pickup changes at Terminals 4, 5, and 7 - shuttle required

Looking to maximize your rewards? Check out the new Atmos Rewards Ascent Visa Signature Card from Bank of America.

How 433 Investors Unlocked 400X Return Potential

Institutional investors back startups to unlock outsized returns. Regular investors have to wait. But not anymore. Thanks to regulatory updates, some companies are doing things differently.

Take Revolut. In 2016, 433 regular people invested an average of $2,730. Today? They got a 400X buyout offer from the company, as Revolut’s valuation increased 89,900% in the same timeframe.

Founded by a former Zillow exec, Pacaso’s co-ownership tech reshapes the $1.3T vacation home market. They’ve earned $110M+ in gross profit to date, including 41% YoY growth in 2024 alone. They even reserved the Nasdaq ticker PCSO.

The same institutional investors behind Uber, Venmo, and eBay backed Pacaso. And you can join them. But not for long. Pacaso’s investment opportunity ends September 18.

Paid advertisement for Pacaso’s Regulation A offering. Read the offering circular at invest.pacaso.com. Reserving a ticker symbol is not a guarantee that the company will go public. Listing on the NASDAQ is subject to approvals.

Keep Reading

No posts found